Introduction Transvaginal mesh implants are commonly used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These conditions affect millions of women worldwide, often causing discomfort and significantly affecting your quality of life. Mesh implants were introduced as a solution to support weakened or damaged tissue. However, these devices have been linked to […]
FDA Ban on Transvaginal Mesh Kits
In 2019, the FDA ban on transvaginal mesh kits for pelvic organ prolapse repair was implemented, responding to reports of severe complications. This article explores the reasons for the ban, the impact on women’s health, and examines possible surgical and non-surgical alternatives. Key Takeaways The FDA banned the sale of all transvaginal mesh products for […]
FDA Continues Studies of the Dangers of Transvaginal Mesh
Even though transvaginal mesh devices used for transvaginal repair of pelvic organ prolapse (“POP”) are no longer commercially available, the FDA has required mesh manufacturers to conduct on-going studies to better understand what impacts the mesh has on women who have already been implanted with the mesh, long term. These studies are collaborative efforts with […]